Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 1
2002 1
2003 3
2004 3
2005 1
2006 5
2007 4
2008 5
2009 2
2010 4
2011 5
2012 6
2013 4
2014 9
2015 4
2017 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 25744424

54 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Active Hexose Correlated Compound (AHCC) in alcohol-induced liver enzyme elevation.
Kim H, Kim JH, Im JA. Kim H, et al. J Nutr Sci Vitaminol (Tokyo). 2014;60(5):348-56. doi: 10.3177/jnsv.60.348. J Nutr Sci Vitaminol (Tokyo). 2014. PMID: 25744424 Free article. Clinical Trial.
Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis.
Mascaraque C, Suárez MD, Zarzuelo A, Sánchez de Medina F, Martínez-Augustin O. Mascaraque C, et al. Mol Nutr Food Res. 2014 Dec;58(12):2379-82. doi: 10.1002/mnfr.201400364. Epub 2014 Oct 2. Mol Nutr Food Res. 2014. PMID: 25186628
Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine.
Roman BE, Beli E, Duriancik DM, Gardner EM. Roman BE, et al. Nutr Res. 2013 Jan;33(1):12-7. doi: 10.1016/j.nutres.2012.11.001. Epub 2012 Dec 4. Nutr Res. 2013. PMID: 23351405 Clinical Trial.
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784
Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.
Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y. Terakawa N, et al. Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280. Nutr Cancer. 2008. PMID: 18791928 Clinical Trial.
Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.
Nogusa S, Gerbino J, Ritz BW. Nogusa S, et al. Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005. Nutr Res. 2009. PMID: 19285605
A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.
Spierings EL, Fujii H, Sun B, Walshe T. Spierings EL, et al. J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9. doi: 10.3177/jnsv.53.536. J Nutr Sci Vitaminol (Tokyo). 2007. PMID: 18202543 Free article. Clinical Trial.
Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Shigama K, et al. J Exp Ther Oncol. 2009;8(1):43-51. J Exp Ther Oncol. 2009. PMID: 19827270
Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC).
Fujii H, Nishioka N, Simon RR, Kaur R, Lynch B, Roberts A. Fujii H, et al. Regul Toxicol Pharmacol. 2011 Mar;59(2):237-50. doi: 10.1016/j.yrtph.2010.10.006. Epub 2010 Oct 14. Regul Toxicol Pharmacol. 2011. PMID: 20951179
Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
Mach CM, Fugii H, Wakame K, Smith J. Mach CM, et al. J Soc Integr Oncol. 2008 Summer;6(3):105-9. J Soc Integr Oncol. 2008. PMID: 19087767
54 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page